Profile of:
Murat Torgutalp
Murat Torgutalp is an internist, rheumatologist, and clinical researcher at Charité – Universitätsmedizin Berlin, Germany. He completed his MSc in Epidemiology at the Berlin School of Public Health and currently serves as the international study coordinator of the AXIS Study. His research focuses on axial spondyloarthritis, with a special interest in clinical outcomes, imaging, and real-world data. Murat has been an ASAS member since 2021.
Full name: Murat Torgutalp
Current country: Germany
Membership level: Full
Type of membership: Member
Number of publications: 31
Radiographic structural damage in axial spondyloarthritis: is there a preferred way to quantify progression over time? Comparison of blinded versus unblinded mSASSS scoring (2025)
https://pubmed.ncbi.nlm.nih.gov/40379523/
Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE (2025)
https://pubmed.ncbi.nlm.nih.gov/40078463/
Complement proteins in axial spondyloarthritis: associations with disease activity and TNFi treatment response in a multicentre RCT (2025)
https://pubmed.ncbi.nlm.nih.gov/39959130/
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis (2025)
https://pubmed.ncbi.nlm.nih.gov/39955166/
Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy (2025)
https://pubmed.ncbi.nlm.nih.gov/39762123/
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy (2025)
https://pubmed.ncbi.nlm.nih.gov/38507706/
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial (2024)
https://pubmed.ncbi.nlm.nih.gov/38228361/
Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/39740933/
Anatomy-centred deep learning improves generalisability and progression prediction in radiographic sacroiliitis detection (2024)
https://pubmed.ncbi.nlm.nih.gov/39719299/
Comparing clinical profiles in spondyloarthritis with Crohn’s disease or ulcerative colitis: insights from the ASAS-PerSpA study (2024)
https://pubmed.ncbi.nlm.nih.gov/38807853/
Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging (2024)
https://pubmed.ncbi.nlm.nih.gov/38580341/
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs (2024)
https://pubmed.ncbi.nlm.nih.gov/38360039/
Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints (2023)
https://pubmed.ncbi.nlm.nih.gov/37093751/
Keep an Eye on the Back: Spondyloarthritis in Patients With Acute Anterior Uveitis (2023)
https://pubmed.ncbi.nlm.nih.gov/35905288/
Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37419620/
Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn’s disease: Clinical and MRI results from a prospective inception cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35227921/
Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/35368376/
Treatment with Tumour Necrosis Factor Inhibitors is Associated with a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients with Axial Spondyloarthritis: 10-year Results from the German Spondyloarthritis Inception Cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35437900/
The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35451472/
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35697486/
Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/36003590/
Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/36323487/
Detection of radiographic sacroiliitis with an artificial neural network in patients with suspicion of axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34363456/
Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance (2021)
https://pubmed.ncbi.nlm.nih.gov/33832519/
Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33796155/
Diagnosing axial spondyloarthritis: estimation of the disease probability in patients with a priori different likelihoods of the diagnosis (2021)
https://pubmed.ncbi.nlm.nih.gov/33693503/
Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial (2021)
https://pubmed.ncbi.nlm.nih.gov/34785545/
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) (2021)
https://pubmed.ncbi.nlm.nih.gov/34987619/
Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa (2020)
https://pubmed.ncbi.nlm.nih.gov/32911279/
IL-17 inhibition in axial spondyloarthritis: current and future perspectives (2019)
https://pubmed.ncbi.nlm.nih.gov/30957574/
Emerging treatment options for spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/31171316/